oxymatrine has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Hu, Y; Li, X; Niu, H; Ou, Y; Wang, S | 1 |
| Jiang, H; Jin, J; Liu, H; Lu, L; Zhang, Y; Zhu, X | 1 |
2 other study(ies) available for oxymatrine and Melanoma
| Article | Year |
|---|---|
Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC/PD-L1 pathway.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Melanoma; Mice; Tumor Microenvironment | 2023 |
The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells.
Topics: Acetylcysteine; Alkaloids; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Melanoma; Oxidative Stress; Quinolizines; Reactive Oxygen Species | 2010 |